Pharmaceutical Compnies Mislead Public About Meds

The pharmaceutical industry as a whole takes in billions annually from its anti depressant drugs that it advertises relentlessly and offers to the public annually at ever increasing costs. According to a review of data submitted to the F.D.A. it is believed that these companies have been engaged in an attempt to mislead the public about the overall efficacy of nearly a dozen anti depressant drugs through selectivly publishing only the studies that favorably review these drugs and down playing the studies that might indicate that the drugs do not have much of an effect or even negativly impact the patient. As a result the public does not recieve an accurate account of how effective these drugs may actually be. They are generally left with the impression that anti depressants are more effective than the research would actually indicate. Generally pharmaceutical companies fear negative publicity about their drugs because that unfavorable information would hurt sales of a new drug and badly effect their bottom lines so that kind of information is suppressed as much as possible in order to protect the economic investment already made in new drugs about to go to market.